Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...
Main Authors: | Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Elsevier
2019
|
相似书籍
-
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
由: Donovan, JL, et al.
出版: (2017) -
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
由: J. Donovan, et al.
出版: (2003-01-01) -
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
由: S. Sanghera, et al.
出版: (2020-10-01) -
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
由: Young, GJ, et al.
出版: (2017) -
Addressing patient treatment preferences at trial recruitment.
由: Mills, N, et al.
出版: (2011)